Charles River Laboratories International logo
Charles River Laboratories International CRL
$ 197.62 2.4%

Quarterly report 2025-Q3
added 11-05-2025

report update icon

Charles River Laboratories International Cash Flow 2011-2025 | CRL

Annual Cash Flow Charles River Laboratories International

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Operating Cash Flow

735 M 684 M 620 M 761 M 547 M 481 M 441 M 318 M 317 M - - - - -

Depreciation & Amortization

362 M 314 M 304 M 266 M 235 M 198 M 162 M 131 M 127 M 94.9 M 96.4 M 96.6 M 81.3 M 85.2 M

Accounts Payables

140 M 169 M 206 M 198 M 122 M 111 M 66.2 M 77.8 M 68.5 M 36.7 M 33.8 M 31.8 M 31.2 M 34.3 M

Accounts Receivables

721 M 780 M 752 M 643 M 618 M 514 M 472 M 430 M 364 M 270 M 258 M 221 M 203 M 185 M

Total Inventories

279 M 380 M 256 M 199 M 186 M 161 M 128 M 115 M 95.8 M 93.7 M 89 M 89.4 M 88.5 M 93 M

All numbers in USD currency

Quarterly Cash Flow Charles River Laboratories International

2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Operating Cash Flow

- - 172 M - - - 130 M - - - 109 M - 385 M - 103 M - 532 M - 170 M - 408 M 231 M 68.6 M - 300 M 144 M 14.9 M - - 184 M 60.1 M - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Depreciation & Amortization

85.2 M 120 M 120 M - 88.2 M 86.1 M 85.4 M - 78.9 M 77.7 M 77.1 M - 74.6 M 76.4 M 75.3 M - 68.7 M 68.1 M 61.5 M - 59.6 M 57.2 M 57.3 M - 51.8 M 49.1 M 45.4 M - 43.6 M 43.4 M 33.2 M - 33.5 M 31.8 M 32.4 M - 34.1 M 32.4 M 24.7 M - 23.8 M 23.1 M 22.4 M - 26.1 M 24.3 M 20 M - 67.3 M 40.4 M 20 M - 60.6 M 40.1 M 20 M - 64.2 M 43.1 M 21.3 M

Accounts Payables

170 M 146 M 149 M 140 M 136 M 133 M - 169 M 136 M 140 M 120 M 206 M 182 M - 226 M 198 M 128 M 111 M 127 M 122 M 122 M 122 M 122 M 111 M 111 M 111 M 111 M 66.2 M 66.2 M 66.2 M 66.2 M 77.8 M 77.8 M 77.8 M 77.8 M 68.5 M 68.5 M 68.5 M 68.5 M 36.7 M 36.7 M 36.7 M 36.7 M 33.8 M 33.8 M 33.8 M 33.8 M 31.8 M 31.8 M 31.8 M 31.8 M 31.2 M 31.2 M 31.2 M 31.2 M 34.3 M 34.3 M 34.3 M 34.3 M

Accounts Receivables

734 M 768 M 757 M 721 M 754 M 762 M - 780 M 799 M 801 M 788 M 752 M 771 M - 698 M 643 M 660 M 644 M 611 M 618 M 618 M 618 M 618 M 514 M 514 M 514 M 514 M 472 M 472 M 472 M 472 M 430 M 430 M 430 M 430 M 364 M 364 M 364 M 364 M 270 M 270 M 270 M 270 M 258 M 258 M 258 M 258 M 221 M 221 M 221 M 221 M 203 M 203 M 203 M 203 M 185 M 185 M 185 M 185 M

Total Inventories

303 M 280 M 290 M 279 M 336 M 349 M - 380 M 293 M 285 M 263 M 256 M 262 M - 221 M 199 M 182 M 194 M 194 M 186 M 186 M 186 M 186 M 161 M 161 M 161 M 161 M 128 M 128 M 128 M 128 M 115 M 115 M 115 M 115 M 95.8 M 95.8 M 95.8 M 95.8 M 93.7 M 93.7 M 93.7 M 93.7 M 89 M 89 M 89 M 89 M 89.4 M 89.4 M 89.4 M 89.4 M 88.5 M 88.5 M 88.5 M 88.5 M 93 M 93 M 93 M 93 M

All numbers in USD currency

Cash Flow Statement is one of the three key financial reports of the company Charles River Laboratories International, reflecting the actual cash inflows and outflows over a certain period. Unlike the income statement, which shows revenues and expenses on an accrual basis, the cash flow statement focuses on real cash flows — how much cash actually came into the company and how much was spent.

Main Sections of the Cash Flow Statement
  • Operating Activities
    This section reflects cash flows related to the company’s core operations: receipts from sales of goods and services, payments to suppliers, employee salaries, taxes, and other operating expenses. Positive cash flow from operating activities indicates the viability of the business and its ability to generate cash.
  • Investing Activities
    Shows cash movements related to the purchase and sale of long-term assets such as real estate, equipment, and investments in other companies. Negative cash flow here often indicates investments in growth, which can be a positive sign.
  • Financing Activities
    Reflects the inflow and outflow of cash related to raising and repaying capital: issuing shares, loans, dividend payments, and loan repayments. This section shows how the company finances its activities and distributes profits.

The cash flow statement is important for investors because it allows them to assess the company’s real liquidity, showing whether it has enough cash to cover current obligations and investments — this is critical for financial stability. Additionally, it helps analyze the quality of earnings, since profits reported in the income statement can be "paper" profits and may not reflect actual cash inflows; the cash flow statement reveals this difference. The presence of free cash is also crucial for evaluating the company’s ability to finance growth and pay dividends, which is important for investors. Attention should also be paid to prolonged negative cash flows from operating activities, as this may serve as a warning sign of potential problems with the core business.

Cash flow statements of other stocks in the Diagnostics research sector

Issuer Price % 24h Market Cap Country
Centogene N.V. Centogene N.V.
CNTG
- -6.23 % $ 30.6 M germanyGermany
Akumin Akumin
AKU
- -17.87 % $ 25.9 M canadaCanada
Brainsway Ltd. Brainsway Ltd.
BWAY
$ 17.27 1.8 % $ 99.4 M israelIsrael
Burning Rock Biotech Limited Burning Rock Biotech Limited
BNR
$ 15.82 0.44 % $ 170 M chinaChina
Accelerate Diagnostics Accelerate Diagnostics
AXDX
- -61.36 % $ 2.46 M usaUSA
Biocept Biocept
BIOC
- -13.05 % $ 7.29 M usaUSA
BioNano Genomics BioNano Genomics
BNGO
$ 1.55 -4.63 % $ 1.97 M usaUSA
DarioHealth Corp. DarioHealth Corp.
DRIO
$ 12.14 2.1 % $ 344 M israelIsrael
DexCom DexCom
DXCM
$ 65.83 -1.69 % $ 25.4 B usaUSA
Castle Biosciences Castle Biosciences
CSTL
$ 39.06 1.11 % $ 1.08 B usaUSA
Chembio Diagnostics Chembio Diagnostics
CEMI
- 0.22 % $ 16.8 M usaUSA
Exact Sciences Corporation Exact Sciences Corporation
EXAS
$ 101.64 0.14 % $ 18.8 B usaUSA
Danaher Corporation Danaher Corporation
DHR
$ 227.72 0.54 % $ 166 B usaUSA
Fulgent Genetics Fulgent Genetics
FLGT
$ 27.0 -0.52 % $ 816 M usaUSA
Global Cord Blood Corporation Global Cord Blood Corporation
CO
- - $ 399 M chinaChina
Genetic Technologies Limited Genetic Technologies Limited
GENE
- - $ 7.1 B australiaAustralia
Genetron Holdings Limited Genetron Holdings Limited
GTH
- 0.12 % $ 80.1 M chinaChina
DermTech DermTech
DMTK
- -11.32 % $ 2.94 M usaUSA
CareDx, Inc CareDx, Inc
CDNA
$ 19.98 -2.82 % $ 1.07 B usaUSA
Celcuity Celcuity
CELC
$ 101.67 -3.4 % $ 4.01 B usaUSA
Enzo Biochem Enzo Biochem
ENZ
- -8.98 % $ 14.8 K usaUSA
Anixa Biosciences Anixa Biosciences
ANIX
$ 3.3 -7.82 % $ 105 K usaUSA
Co-Diagnostics Co-Diagnostics
CODX
$ 0.29 -14.47 % $ 8.51 M usaUSA
IQVIA Holdings IQVIA Holdings
IQV
$ 222.75 0.24 % $ 40.4 B usaUSA
Guardant Health Guardant Health
GH
$ 103.7 1.6 % $ 12.7 B usaUSA
Aspira Women's Health Aspira Women's Health
AWH
- -6.19 % $ 10.5 M usaUSA
Heska Corporation Heska Corporation
HSKA
- - $ 1.31 B usaUSA
HTG Molecular Diagnostics HTG Molecular Diagnostics
HTGM
- -20.0 % $ 1.06 M usaUSA
Illumina Illumina
ILMN
$ 134.4 -0.35 % $ 21.4 B usaUSA
Quotient Limited Quotient Limited
QTNT
- -11.32 % $ 1.1 M schweizSchweiz
Mettler-Toledo International Mettler-Toledo International
MTD
$ 1 410.02 1.15 % $ 29.9 B schweizSchweiz
Quest Diagnostics Incorporated Quest Diagnostics Incorporated
DGX
$ 183.96 0.79 % $ 20.4 B usaUSA
NeoGenomics NeoGenomics
NEO
$ 12.03 1.48 % $ 1.52 B usaUSA
Neogen Corporation Neogen Corporation
NEOG
$ 6.85 -0.22 % $ 1.49 B usaUSA
Biodesix Biodesix
BDSX
$ 7.63 -2.8 % $ 989 M usaUSA
Myriad Genetics Myriad Genetics
MYGN
$ 7.04 -2.36 % $ 638 M usaUSA
Laboratory Corporation of America Holdings Laboratory Corporation of America Holdings
LH
$ 262.89 -0.48 % $ 22.1 B usaUSA
ICON Public Limited Company ICON Public Limited Company
ICLR
$ 184.38 -1.18 % $ 15.2 B irlandaIrlanda
IDEXX Laboratories IDEXX Laboratories
IDXX
$ 698.77 -0.77 % $ 57.6 B usaUSA
Lantheus Holdings Lantheus Holdings
LNTH
$ 66.4 -0.33 % $ 4.59 B usaUSA
Agilent Technologies Agilent Technologies
A
$ 140.3 0.46 % $ 42.7 B usaUSA
Biomerica Biomerica
BMRA
$ 2.48 -2.65 % $ 5.7 M usaUSA
Bioventus Bioventus
BVS
$ 7.49 -0.86 % $ 469 M usaUSA
Check-Cap Ltd. Check-Cap Ltd.
CHEK
- - $ 9.42 M israelIsrael
Pacific Biosciences of California Pacific Biosciences of California
PACB
$ 2.13 0.24 % $ 540 M usaUSA
Motus GI Holdings Motus GI Holdings
MOTS
- -34.28 % $ 263 K israelIsrael